
Bruker Corporation BRKR
$ 45.69
1.58%
Quarterly report 2026-Q1
added 05-07-2026
Bruker Corporation DSO Ratio 2011-2026 | BRKR
Annual DSO Ratio Bruker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59 | 57.3 | 59.4 | 64.2 | 56.8 | 61.6 | 63.8 | 68.8 | 66 | 55.2 | 52.8 | 59.2 | 61 | 58.9 | 62.5 | 32.6 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 68.8 | 32.6 | 58.7 |
Quarterly DSO Ratio Bruker Corporation
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60.6 | 56.9 | 60.7 | 62.8 | - | 55.2 | 28.9 | 31.1 | - | 57.5 | 61.7 | 62.9 | - | 30.1 | 32.1 | 63.7 | - | 53.1 | 53 | 54.4 | - | 59.8 | 72.1 | 75.1 | 55.1 | 63.4 | 67.4 | 71.1 | 58.9 | 69.9 | 73.5 | 71.5 | 54.9 | 66.9 | 70.2 | 66.8 | 47.3 | 56.5 | 59.9 | 58.2 | 44.8 | 54.1 | 54.1 | 68.1 | 52.7 | 63.7 | 58.5 | 64.7 | 50.8 | 63.9 | 61.7 | 69.2 | 51 | 59 | 62.8 | 64.3 | 54.3 | 61.7 | 64.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75.1 | 28.9 | 58.6 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
50.8 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
IRIDEX Corporation
IRIX
|
26.4 | $ 1.01 | - | $ 17.1 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 11.44 | -2.22 % | $ 324 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 8.27 | 0.49 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
104 | $ 4.3 | -2.27 % | $ 161 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 73.83 | 0.26 % | $ 4.03 B | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
LENSAR
LNSR
|
38.9 | $ 6.09 | 2.35 % | $ 72.8 M | ||
|
Helius Medical Technologies
HSDT
|
2.12 | $ 2.29 | -2.97 % | $ 50.5 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.46 | 0.17 % | $ 28.6 M | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 18.37 | -0.33 % | $ 431 M | ||
|
Delcath Systems
DCTH
|
48.5 | $ 11.02 | -3.76 % | $ 395 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
MiMedx Group
MDXG
|
57.3 | $ 3.62 | 0.28 % | $ 535 M | ||
|
Pulmonx Corporation
LUNG
|
50.8 | $ 1.55 | 0.65 % | $ 63.1 M | ||
|
Electromed
ELMD
|
137 | $ 38.22 | -0.93 % | $ 323 M | ||
|
Myomo
MYO
|
35.3 | $ 1.04 | 9.5 % | $ 43.5 M | ||
|
Butterfly Network
BFLY
|
88.9 | $ 4.47 | -0.11 % | $ 1.1 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Sintx Technologies
SINT
|
67 | $ 2.39 | 3.91 % | $ 6.63 M | ||
|
Orthofix Medical
OFIX
|
60 | $ 10.75 | 3.27 % | $ 426 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Profound Medical Corp.
PROF
|
161 | $ 6.83 | -2.01 % | $ 206 M | ||
|
Globus Medical
GMED
|
76.8 | $ 84.81 | 0.24 % | $ 11.5 B | ||
|
Insulet Corporation
PODD
|
15.2 | $ 154.87 | -1.29 % | $ 10.9 B | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 37.23 | 0.57 % | $ 1.16 B | ||
|
Inspire Medical Systems
INSP
|
42.6 | $ 43.84 | -2.01 % | $ 1.29 B | ||
|
Integer Holdings Corporation
ITGR
|
58.2 | $ 89.28 | -0.8 % | $ 3.1 B | ||
|
TransMedics Group
TMDX
|
54.9 | $ 68.94 | 0.12 % | $ 2.34 B | ||
|
Invacare Corporation
IVC
|
206 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 85.78 | 3.1 % | $ 50.2 B |